It sounds simple, but in reality, it's quite complicated to operate. Although this method may have misjudgments, as long as the accuracy reaches a certain level, it can save a lot of funds for R&D and avoid unnecessary investments.
It's like there's a software that can predict all stock fluctuations. It doesn't need to predict every stock accurately; it just needs the accuracy probability to exceed a certain threshold. Following the software's guidance, some stocks will earn, and some will lose, but once the software's prediction accuracy exceeds the break-even point and remains stable above it, the person will always profit without loss.
In fact, the real technical barrier for some pharmaceutical giants isn't the several drugs already on the market, but the powerful R&D system behind them. The core of this is the database accumulated from past R&D, which can not only prevent new drug R&D from taking wrong detours but also guide new drug development in the right direction.
